Drug intelligence / Profile preview

Estradiol sulfamate

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Subcutaneous
01

Overview

Estradiol sulfamate is a synthetic steroid, specifically a C3 sulfamate ester of estradiol. It was initially conceived as an orally active prodrug of estradiol, designed to achieve higher systemic and reduced hepatic estrogenic activity compared to direct estradiol administration. While it can accumulate in erythrocytes and undergo systemic hydrolysis to release estradiol, subsequent research, particularly in humans, has revealed its potent steroid sulfatase (STS) inhibitory activity. This inhibition prevents the conversion of inactive steroid sulfates into active estrogens, including its own bioactivation into estradiol, thereby effectively abolishing its estrogenic activity in humans and leading to anti-estrogenic effects in certain tissues. It has been investigated for applications in hormone replacement therapy, fertility control, and endometriosis.

Other names
estradiol-3-O-sulfamateestradiol3-O-sulfamateestradiol 3-O-sulfamate17β-Hydroxyestra-1,3,5(10)-trien-3-yl sulfamateEstra-1,3,5(10)-triene-3,17-diol (17β)-, 3-sulfamateEstradiol 3-sulfamateEstradiol3-sulfamateEstradiol-3-sulfamate
02

Targets

STS (Steroid sulfatase)

Beyond the preview

Go deeper on Estradiol sulfamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estradiol sulfamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call